1.89 USD
↗ 0.09 (5.00%)AT CLOSE (11:59 AM EDT)
Palisade Bio, Inc. Common Stock
PALINASDAQ • USD
1.89
↘ 0.01 (0.27%)
POST MARKET (AS OF 06:57 PM EDT)
Post Market
AS OF 06:57 PM EDT
1.89
↘ 0.01 (0.27%)
Market: CLOSED
Palisade Bio, Inc. Common Stock (PALI) trades at $1.89 per share. PALI shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, PALI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$1.80
High?$1.90
Low?$1.78
Prev. Close?$1.80
Volume?23.2M
Avg. Volume?3.4M
VWAP?$1.84
Rel. Volume?6.81x
Bid / Ask
Bid?$1.88 × 1.2K
Ask?$1.89 × 2.7K
Spread?$0.01
Midpoint?$1.88
Valuation & Ratios
Market Cap?328.4M
Shares Out?173.6M
Float?165.0M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.58
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
312.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?31.89Safe
Confidence?45%Low
Short InterestVery High
Short % of Float?19.11%High
Short Interest?31.5M
Days to Cover?11.9
Free Float165.0M
Avg Daily Volume2.6M
Settlement Date2026-06-15
Financial Health
Current Ratio?23.71Strong
Quick Ratio?23.71Strong
Cash Ratio?23.60Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.58CHEAP▾
Peers100
S&P63
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-19.0%WEAK▾
S&P8
ROA?-18.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$195.8M
Fundamentals ratios updated end of day